Cryo Cell International (CCEL) Common Equity (2016 - 2025)
Historic Common Equity for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to -$14.8 million.
- Cryo Cell International's Common Equity fell 5515.71% to -$14.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$14.8 million, marking a year-over-year decrease of 5515.71%. This contributed to the annual value of -$13.2 million for FY2024, which is 1980.54% down from last year.
- Cryo Cell International's Common Equity amounted to -$14.8 million in Q3 2025, which was down 5515.71% from -$15.6 million recorded in Q2 2025.
- In the past 5 years, Cryo Cell International's Common Equity ranged from a high of $4.8 million in Q3 2021 and a low of -$15.6 million during Q2 2025
- In the last 5 years, Cryo Cell International's Common Equity had a median value of -$1.7 million in 2021 and averaged -$4.5 million.
- As far as peak fluctuations go, Cryo Cell International's Common Equity soared by 35079.73% in 2022, and later plummeted by 5904097.63% in 2024.
- Over the past 5 years, Cryo Cell International's Common Equity (Quarter) stood at $4.2 million in 2021, then plummeted by 136.43% to -$1.5 million in 2022, then plummeted by 623.69% to -$11.0 million in 2023, then fell by 19.81% to -$13.2 million in 2024, then decreased by 12.22% to -$14.8 million in 2025.
- Its Common Equity was -$14.8 million in Q3 2025, compared to -$15.6 million in Q2 2025 and -$14.7 million in Q1 2025.